Involvement of interleukin-1 in lipopolysaccaride-induced microglial activation and learning and memory deficits

Journal of Neuroscience Research

Volumn 89, Issue 4, 2011, Pages 506-514

  Tanaka, S ^a   Kondo, H ^a   Kanda, K ^a   Ashino, T ^a   Nakamachi, T ^a   Sekikawa, K ^b   Iwakura, Y ^c   Shioda, S ^a   Numazawa, S ^a   Yoshida, T ^a  

^a SHOWA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

IL 1 ; Knockout mouse; Memory; Neuroinflammation; TNF

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LEARNING DISORDER; MALE; MEMORY DISORDER; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-1; LEARNING DISORDERS; LIPOPOLYSACCHARIDES; MALE; MEMORY DISORDERS; MICE; MICE, KNOCKOUT; MICROGLIA; RECEPTORS, N-METHYL-D-ASPARTATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79751504023     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22582     Document Type: Article

References (52)

1. Bliss TV, Collingridge GL. 1993. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361: 31-39.
2. Bo L, Monk S, Kong P, Nyland H, Pardo C, Trapp B. 1994. Detection of MHC class II antigens on macrophages and microglia, but not on astrocyte and endothelia in active multiple sclerosis lesions. J Neuroimmunol 51: 135-146.
3. Bonmann E, Suschek C, Spranger M, Bachofen V. 1997. The dominant role of exogenous or endogenous interleukin-1 beta on expression and activity of inducible nitric oxide synthase in rat microvascular brain endothelial cells. Neurosci Lett 230: 109-112.
4. Brugg B, Dubreuil G, Huber E, Wollman EE, Delhaye-Bouchaud N, Mariani J. 1995. Inflammatory processes induce β-amyloid precursor protein changes in mouse brain. Proc Natl Acad Sci U S A 92: 3032-3035.
5. Cacci E, Claasen JH, Kokaia Z. 2005. Microglia-derived tumor necrosis factor-alpha exaggerates death of newborn hippocampal progenitor cells in vitro. J Neurosci Res 80: 789-797.
6. Cai Z, Pang Y, Lin S, Rhodes P. 2003. Differential roles of tumor necrosis factor-α and interleukin-1β on lipopolysaccharide-induced brain injury in the neonatal rat. Brain Res 975: 37-47.
7. Cull-Candy S, Brickley S, Farrant M. 2001. NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 11: 327-335.
8. Davis S, Butcher SP, Morris RG. 1992. The NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro. J Neurosci 12: 21-34.
9. Dickson DW, Lee SC, Mattiace LA, Yen SH, Brosnan C. 1993. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7: 78-83.
10. Ekdahl CT, Classen JH, Bonde S, Kokaia Z.Lindvall O. 2003. Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci U S A 100: 13632-13637.
11. Fan LW, Lin S, Pang Yi, Rhodes PG, Cai Z. 2006. Minocycline attenuates hypoxia-ischemia-induced neurological dysfunction and brain injury in the juvenile rat. Eur J Neurosci 24: 341-350.
12. Fogal B, Hewett JA, Hewett SJ. 2005. Interleukin-1 beta potentiates neuronal injury in a variety of injury models involving energy deprivation. J Neuroimmunol 161: 93-100.
13. Gayle D, Ling Z, Tong C, Landers T, Lipton JW, Carvey PM. 2002. Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide. Brain Res Dev Brain Res 133: 27-35.
14. Gibertini M, Newton C, Fredman H, Klein TW. 1995. Spatial learning in mice infected with Legionella pneumophila or administered exogenous interleukin-1β. Brain Behav Immun 9: 113-128.
15. Harre EM, Galic MA, Mouihate A, Noorbakhsh F, Pittman QJ. 2008. Neonatal inflammation produces selective behavioural deficits and alters N-methyl-D aspartate receptor subunit mRNA in the adult rat brain. Eur J Neurosci 27: 644-653.
16. Hauss-Wegrzyniak B, Dobrzanski P, Stoehr JD, Wenk G. 1998. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's. Brain Res 780: 294-303.
17. Hauss-Wegrzyniak B, Lynch A, Vraniak P.Wenk G. 2002. Chronic brain inflammation results in cell loss in the entorhinal cortex and impaired LTP in perforant path-granule cell synapses. Exp Neurol 176: 336-341.
18. Horai R, Asano M, Sudo K, Kanuka H, Suzuki M, Nishihara M, Takahashi M, Iwakura Y. 1998. Production of mice deficient in genes for interleukin (IL)-1 alpha, IL-1 beta, IL1 alpha/beta, and IL-1 receptor antagonist shows that IL-1 beta is crucial in turpentine-induced fever development and glucocorticoid secretion. J Exp Med 187: 1463-1475.
19. Hu W, Ranaivo HR, Roy SM, Behanna HA, Wing LK, Munoz L, Guo L, Van Eldik LJ, Watterson DM. 2007. Development of a novel therapeutic suppressor of brain proinflammatory cytokine up-regulation that attenuates synaptic dysfunction and behavioral deficits. Bioorg Med Chem Lett 17: 414-418.
20. In't Veld BA, Ruitenberg A, Hofman A, Launer LJ, Van Duijn CM, Stijen T, Breteler MM, Stricker BH. 2001. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 345: 1515-1521.
21. Kim SU, de Vellis J. 2005. Microglia in health and disease. J Neurosci Res 81: 302-313.
22. Kohr G, Jensen V, Koester HJ, Mihaljevic AL, Utvik JK, Kvello A, Ottersen OP, Seeburg PH, Sprengel R, Hvalby O. 2003. Intracellular domains of NMDA receptor subtypes are determinants for long-term potentiation induction. J Neurosci 23: 10791-10799.
23. Kuno RJ, Kawanokuchi J, Takeuchi H, Mizuno T, Suzumura A. 2005. Autocrine activation of microglia by tumor necrosis factor-α. J Neuroimmunol 162: 89-96.
24. Malgaroli A, Tsien RW. 1992. Glutamate-induced long term potentiation of the frequency of miniature synaptic currents in cultured hippocampal neurons. Nature 357: 134-139.
25. McGeer EG, McGeer PL. 1998. The importance of inflammatory mechanisms in Alzheimer disease. Exp Gerontol 33: 371-378.
26. McGeer PL, Itagaki S, Boyes BE, McGeer EG. 1988. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38: 1285-1291.
27. Meda L, Cassatella MA, Szendrei GI, Otvos LJr, Baron P, Villalba M, Ferrari D, Rossi F. 1995. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 374: 647-650.
28. Mizushima H, Zhou DJI, Dohi K, Horai R, Asano M, Iwakura Y, Hirabayashi T, Arata S, Nakajo S, Takaki A, Ohtaki H, Shioda S. 2002. Reduced postischemic apoptosis in the hippocampus of mice deficient in interleukin-1. J Comp Neurol 448: 203-216.
29. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH. 1994. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12: 529-540.
30. O'Cornnor JJ, Coogan AN. 1999. Actions of the pro-inflammatory cytokine IL-1 beta on central synaptic transmission. Exp Physiol 84: 601-614.
31. Ohtaki H, Funahashi H, Dohi K, Oguro T, Horai R, Asano M, Owalira Y, Yin Li, Matsunaga M, Goto N, Shioda S. 2003. Suppression of oxidative neuronal damage after transient middle cerebral artery occlusion in mice lacking interleukin-1. Neurosci Res 45: 313-324.
32. Oitzl MS, van Oer H, Schobitz B, de Kloet ER. 1993. Interleukin-1 beta, but not interleukin-6, impairs spatial navigation learning. Brain Res 613: 160-163.
33. Quan N, Sundar SK, Weiss JM. 1994. Induction of interleukin-1 in various brain regions after peripheral and central injections of lipopolysaccharide. J Neuroimmunol 49: 125-134.
34. Prybylowski K, Wenthold RJ. 2004. N-Methyl-D-aspartate receptors: subunit assembly and trafficking to the synapse. J Bio Chem 279: 9673-9676.
35. Remarque EJ, Bollen EL, Weverlomg-Rijnsburger AW, Laterveer JC, Blauw GJ, Westendorp RG. 2001. Patients with Alzheimer's disease display a pro-inflammatory phenotype. Exp Gerontol 36: 171-176.
36. Rosi S, Ramirez-Amaya V, Hauss-Wegrzyniak B, Wenk GL. 2004. Chronic brain inflammation leads to a decline in hippocampal NMDA-R1 receptors. J Neuroinflammation 1: 1-9.
37. Sakimura K, Kutsuwada T, Ito I, Manabe T, Takayama C, Kushiya E, Yagi T, Aizawa S, Inoue Y, Sugiyama H, Mishina M. 1995. Reduced hippocampal LTP and Spatial learning in mice lacking NMDA receptor epsilon1 subunit. Nature 373: 151-155.
38. Selmaj KW, Raine CS. 1988. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23: 339-346.
39. Serou MJ, Decoster MA, Bazan NG. 1999. Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression. J Neurosci Res 58: 593-598.
40. Shaw K, Commins S, O'Mara S. 2001. Lipopolysaccharide causes deficits in sptial learning in the watermaze but not in BDNF expression in the rat dentate gyrus. Behav Brain Res 124: 47-54.
41. Tagawa Y, Sekikawa K, Iwakura Y. 1997. Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role forIFN-gamma in activating apoptosis of hepatocyte. J Immunol 159: 1418-1428.
42. Takeuchi H, Jin S, Wang J, Zhang G, Kawanokuchi J, Kuno R, Sonobe Y, Mizuno T, Suzumura A. 2006. Tumor necrosis factor-α induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem 281: 21362-21368.
43. Tanaka S, Ide M, Shibutani T, Ohtaki H, Numazawa S, Shioda S, Yoshida T. 2006. Lipopolysaccharide-induced microglial activation induces learning and memory deficits without neuronal cell death in rats. J Neurosci Res 83: 557-566.
44. Tarkowski E, Andreasen N, Tarkowski A, Blennow K. 2003. Intrathecal inflammation precedes development of Alzheimer's disease. J Neurol Neurosurg Psychiatry 74: 1200-1205.
45. Venters HD, Dantzer R, Kelley KE. 2000. A new concept in neurodegeneration: TNFα is a silencer of survival signals. Trends Neurosci 23: 175-180.
46. Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, Binaglia M, Corsini E, Di Luca M, Galli CL, Marinovich M. 2003. Interleukin-1β enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 23: 8692-8700.
47. Viviani B, Gardoni F, Bartesaghi S, Corsini E, Facchi A, Galli CL, Di Luca M, Marinovich M. 2006. Interleukin-1β released by gp120 drives neural death through tyrosine phosphorylation and trafficking of NMDA receptors. J Biol Chem 281: 30212-30222.
48. Wenk G, McGann K, Hauss-Wegrzyniak B, Rosi S. 2003. The toxicity of tumor necrosis factors-a upon cholinergic neurons within the nucleus basalis and the role of norepinephrine in the regulation of inflammation: implications for alzheimer's. Neuroscience 121: 719-729.
49. Wenk G, McGann K, Hauss-Wegrzyniak B, Ronchetti D.Maucci R, Rosi S, Gasparini L, Ongini E. 2004. Attenuation of chronic neuroinflammation by a nitric oxide releasing derivative of the antioxidant ferulic acid. J Neurochem 89: 484-493.
50. Yirmiya R, Winocur G, Goshen I. 2002. Brain interleukin-1 is involved in spatial memory and passive avoidance conditioning. Neurobiol Learn Mem 78: 379-389.
51. Zassler B, Weis C, Humpel C. 2003. Tumor necrosis factor-α triggers cell death of sensitized potassium chloride-stimulated cholinergic neurons. Brain Res Mol Brain Res 113: 78-85.
52. Zhou Y, Takahashi E, Li W, Halt A, Wiltgen B, Ehninger D, Li GD, Hell JW, Kennedy MB, Silva AJ. 2007. Interactions between the NR2B receptor and CaMKII modulate synaptic plasticity and spatial learning. J Neurosci 27: 13843-13853.